Bloomberg - (BLOOM)
Apr. 11, 2007. 03:38 PM EST
Could a better treatment for this incurable disease be at hand? Phase III trial results so far bode well for this small company, which is looking for a development partner. Dr. Gillespie took over leadership of the firm last month, replacing Steven Engle.